Yael Brenner, VP Quality at Kamada Ltd, filed a statement of changes in beneficial ownership on September 23, 2026, disclosing an adjustment to a previously reported employee stock option grant dated August 27, 2026.
Key Highlights
- Reporting person: Yael Brenner, identified as VP Quality at Kamada Ltd (NASDAQ:KMDA)
- Option grant: 60,000 Employee Stock Options (right to buy) acquired on August 27, 2026, under transaction code A
- Adjusted exercise price: $7.44 per share, converted from NIS using the Bank of Israel exchange rate as of September 22, 2026
- Prior reported price: The option was previously reported at an exercise price of $7.61, adjusted in connection with a special cash dividend declared by the board on August 17, 2026
- Vesting schedule: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the grant date
- Beneficial ownership following transaction: 60,000 derivative securities held indirectly by a trustee under the Company's 2011 Share Award Plan
Kamada Option Exercise Price Revised After Special Cash Dividend
According to the filing, Yael Brenner, serving as VP Quality at Kamada Ltd, reported a derivative securities transaction involving 60,000 Employee Stock Options granting the right to buy ordinary shares. The transaction date is listed as August 27, 2026, which also served as the record date for a special cash dividend declared by Kamada's board of directors on August 17, 2026. The filing discloses that the exercise price adjustment was made directly in connection with that dividend distribution.
The filing states that the exercise price of $7.44, presented in U.S. dollars, represents a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 22, 2026. The option, previously reported as covering 60,000 ordinary shares at an exercise price of $7.61, was revised downward to $7.44 following the special cash dividend event. The 60,000 options are held indirectly through a trustee under the Company's 2011 Share Award Plan, with a price of derivative security listed as $0.00. Kamada Ltd is a biopharmaceutical company whose ordinary shares trade on NASDAQ:KMDA.
The vesting terms disclosed in the filing specify that options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. Following the reported transaction, Brenner beneficially owns 60,000 derivative securities in total, all held indirectly. No non-derivative securities transactions were reported in Table I of the filing.
What Was Disclosed
The filing reports an adjustment to a previously disclosed employee stock option grant held by Kamada's VP Quality, reflecting a lower exercise price following a special cash dividend, with all 60,000 options held indirectly through a trustee under the 2011 Share Award Plan.



Please wait processing your request...